Last Price
Where today's price sits in its 52-week range
Navana Pharmaceuticals PLC ওষুধ ও রসায়ন খাতের একটি কোম্পানি। সব মিলিয়ে কোম্পানিটি ভালো অবস্থায় আছে (আমাদের বিশ্লেষণে 100-এর মধ্যে 72)। কোম্পানিটি লাভজনক এবং গত বছরের তুলনায় এর মুনাফা বেড়েছে। একই ধরনের অন্যান্য কোম্পানির তুলনায় এই শেয়ারটির দাম এখন তুলনামূলক কম। কোম্পানিটি কিছুটা ডিভিডেন্ড দেয় (বছরে প্রায় 1.9%)।
এটি শিক্ষামূলক তথ্য, বিনিয়োগ পরামর্শ নয়।
Buy
Long-term holdGood company, price moving up steadily
Five quick checks that tell you whether this company is healthy, fairly priced, and worth holding.
Looks cheap right now — priced below its usual level.
P/E Ratio
16.1
Price per ৳1 of yearly earnings
Dividend Yield
1.90%
Annual cash return on the price
P/B Ratio
1.6
Price per ৳1 of net assets
Trading at 16.1 — below its 5-year average of 22.3.
The raw figures behind the verdict — for the curious.
EPS
৳4.54
Earnings per share (latest year)
P/E Ratio
11.1
Price you pay per ৳1 of earnings
Dividend Yield
1.90%
Annual cash return on the price
Reserve & Surplus
৳408 Cr
Company's accumulated savings
Total Loan
৳6.3 Cr
Outstanding debt the company carries
Are they making money — and do they share it with shareholders?
Yearly Profit
Net profit per year
Made a profit every year for 5 years.
Earnings Per Share
Profit you earn per share
Earnings per share have been growing — ৳4.5 latest.
Yearly Cash Dividend
% of face value
📢 New 14% dividend just declared — record 19 Nov 2025
Paid a dividend every year for 4 years running.
The deeper numbers — revenue, margins, debt and cash quality over the years.
What the share price has been doing over the last week.
Up 1.7% in the past week, beating the overall market.
Past week
+1.7%
Price move over 7 days
Vs market
+0.9%
Ahead/behind the DSEX index
Trading volume
0.8×
vs its normal volume
Up days
3/7
Green days this week
52-week spot
93%
Position in 1-year range
Trades around ৳6.6 Cr a day on average over the past week.
The good signs and the things to keep an eye on.
Good signs
NAVANAPHAR scores below the other strong names in its sector shown here.
| Stock | ||||||
|---|---|---|---|---|---|---|
| MARICO | 84 | ৳2,731 | +0.1% | 14.6 | +14.1% | +78.4% |
| SQURPHARMA | 82 | ৳221 | -0.8% | 8.2 | +5.4% | +14.8% |
| KOHINOOR | 78 | ৳513 | +0.9% | 30.1 | +1.3% | +26.2% |
| RECKITTBEN | 74 | ৳3,326 | +0.2% | 19.2 | +5.2% | +45.4% |
| ACMELAB | 73 | ৳84.5 | +0.4% | 7.4 | +4.1% | +9.1% |
| NAVANAPHAR | 72 | ৳73.3 | +1.5% | 16.1 | +1.9% | +8.9% |
Who's behind this company — and how committed are they? As of Mar 2026, compared with Jun 2025.
Good sign — owners (sponsors) raised their stake from 31.6% to 42.2% since Jun 2025. People close to the company are buying.
Owners (sponsors) hold 42% — a strong sign of commitment.
Recent news and announcements about this company.